Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 2:58 pm Purchase |
2022-12-30 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 2,569,263 5.640% |
2,569,263 (New Position) |
Filing History |
| 2023-02-06 06:01 am Unchanged |
2022-12-31 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 5.500% |
0 (Unchanged) |
Filing History |
| 2023-02-03 07:28 am Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 6.510% |
796,885 (New Position) |
Filing History |
| 2023-02-03 06:02 am Unchanged |
2021-07-16 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-02 06:02 am Sale |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,919,603 8.000% |
-198,884 (-4.83%) |
Filing History |
| 2023-02-02 06:02 am Unchanged |
2022-12-31 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS CORP UTHR |
2,869,517 3.890% |
0 (Unchanged) |
Filing History |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
BLACKROCK INC BLK |
4,510,211 9.900% |
271,036 (+6.39%) |
Filing History |
| 2023-01-17 06:02 am Sale |
2022-12-31 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS CORP UTHR |
2,869,517 3.890% |
-786,575 (-21.51%) |
Filing History |
| 2022-02-11 3:50 pm Sale |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 2,917,191 6.480% |
-690,100 (-19.13%) |
Filing History |
| 2022-02-11 10:02 am Purchase |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 3,035,000 6.700% |
185,000 (+6.49%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,160,963 9.240% |
196,962 (+4.97%) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,523,378 5.602% |
200,695 (+8.64%) |
Filing History |
| 2022-02-04 4:31 pm Purchase |
2021-07-16 | 13G | Celularity Operations Inc. | UNITED THERAPEUTICS CORP UTHR |
7,968,848 6.510% |
7,968,848 (New Position) |
Filing History |
| 2022-02-04 4:31 pm Purchase |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 4,118,487 8.500% |
489,001 (+13.47%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
BLACKROCK INC BLK |
4,239,175 9.400% |
-33,949 (-0.79%) |
Filing History |
| 2022-01-14 4:30 pm Sale |
2021-12-31 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS CORP UTHR |
3,656,092 5.880% |
-512,722 (-12.30%) |
Filing History |
| 2021-03-01 4:30 pm Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,629,486 7.600% |
3,629,486 (New Position) |
Filing History |
| 2021-02-12 08:08 am Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 2,850,000 6.400% |
2,850,000 (New Position) |
Filing History |
| 2021-02-11 2:18 pm Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 3,607,291 8.120% |
62,858 (+1.77%) |
Filing History |
| 2021-02-10 11:57 am Sale |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 3,964,001 8.920% |
-88,046 (-2.17%) |
Filing History |